bionomics ltd
Australian Company’s Anti-Anxiety Drug Shows Promise
Australian Drug development company Bionomics Limited has successfully concluded two Phase Ib clinical trials of anti-anxiety drug BNC210.
Australian Drug development company Bionomics Limited has successfully concluded two Phase Ib clinical trials of anti-anxiety drug BNC210.
